Chmielewski, R. & Swayne, D. E. Avian influenza: public health and food safety concerns. Annu. Rev. Food Sci. Technol. 2, 37–57 (2011).
Google Scholar
Szucs, T. et al. Economic and social impact of epidemic and pandemic influenza. Vaccine 24, 6776–6778 (2006).
Basuno, E., Yusdja, Y. & Ilham, N. Socio‐economic impacts of avian influenza outbreaks on small‐scale producers in Indonesia. Transbound. Emerg. Dis. 57, 7–10 (2010).
Google Scholar
Govindaraj, G. et al. Economic impacts of avian influenza outbreaks in Kerala, India. Transbound. Emerg. Dis. 65, e361–e372 (2018).
Google Scholar
Capua, I. & Alexander, D. J. Avian influenza: recent developments. Avian Pathol. 33, 393–404 (2004).
Google Scholar
World Organisation for Animal Health (OIE). Avian influenza (including infection with high pathogenicity avian influenza viruses. Terrestrial manual online access: manual of diagnostic tests and vaccines for terrestrial animals. https://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.03.04_AI.pdf. Accessed 30 July 2021 (2021).
Tian, G. et al. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 341, 153–162 (2005).
Google Scholar
van Der Goot, J. A., Koch, G., de Jong, M. C. M. & van Boven, M. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc. Natl. Acad. Sci. USA 102, 18141 (2005).
Google Scholar
Lee, C. W. & Suarez, D. L. Avian influenza virus: prospects for prevention and control by vaccination. Anim. Heal. Res. Rev. 6, 1–15 (2005).
Lardinois, A. et al. Stronger interference of avian influenza virus-specific than newcastle disease virus-specific maternally derived antibodies with a recombinant NDV-H5 vaccine. Avian Dis. 60, 191–201 (2016).
Google Scholar
Naeem, K., Siddique, N., Ayaz, M. & Jalalee, M. A. Avian influenza in pakistan: outbreaks of low- and high-pathogenicity avian influenza in Pakistan during 2003–2006. Avian Dis. 51, 189–193 (2007).
Google Scholar
Bashashati, M., Vasfi, M. M., Bozorgmehri Fard, M. H. & Hashemzadeh, M. Efficacy of inactivated H9N2 avian influenza vaccine against non-highly pathogenic A/Chicken/Iran/ZMT-173/1999 infection. Archiv. Razi Instit. 54, 23–32 (2002).
Liu, S. et al. Control of avian influenza in China: strategies and lessons. Transbound. Emerg. Dis. 67, 1463–1471 (2020).
Google Scholar
Capua, I. & Alexander, D. J. Avian influenza vaccines and vaccination in birds. Vaccine 26, D70–D73 (2008).
Google Scholar
Baintner, K. Transmission of antibodies from mother to young: evolutionary strategies in a proteolytic environment. Vet. Immunol. Immunopathol. 117, 153–161 (2007).
Google Scholar
Brambell, F. W. R. The transmission of immune globulins from the mother to the foetal and newborn young. Proc. Nutr. Soc. 28, 35–41 (1969).
Google Scholar
Loeken, M. R. & Roth, T. F. Analysis of maternal IgG subpopulations which are transported into the chicken oocyte. Immunology 49, 21 (1983).
Google Scholar
Patterson, R., Youngner, J. S., Weigle, W. O. & Dixon, F. J. Antibody production and transfer to egg yolk in chickens. J. Immunol. 89, 272–278 (1962).
Google Scholar
Brierley, J. & Hemmings, W. A. The selective transport of antibodies from the yolk sac to the circulation of the chick. Development 4, 34–41 (1956).
Tesar, D. B., Cheung, E. J. & Bjorkman, P. J. The chicken yolk sac IgY receptor, a mammalian mannose receptor family member, transcytoses IgY across polarized epithelial cells. Mol. Biol. Cell 19, 1587 (2008).
Kramer, T. T. & Cho, H. C. Transfer of immunoglobulins and antibodies in the hen’s egg. Immunology 19, 1587–1593 (2008).
Kowalczyk, K., Daiss, J., Halpern, J. & Roth, T. F. Quantitation of maternal-fetal IgG transport in the chicken. Immunology 54, 755–762 (1985).
Google Scholar
Mast, J. & Goddeeris, B. M. Development of immunocompetence of broiler chickens. Vet. Immunol. Immunopathol. 70, 245–256 (1999).
Al-Natour, M. Q., Ward, L. A., Saif, Y. M., Stewart-Brown, B. & Keck, L. D. Effect of different levels of maternally derived antibodies on protection against infectious bursal disease virus. Avian Dis. 48, 177–182 (2004).
Google Scholar
Carlier, Y. & Truyens, C. Influence of maternal infection on offspring resistance towards parasites. Parasitol. Today 11, 94–99 (1995).
Google Scholar
Lemke, H., Tanasa, R. I., Trad, A. & Lange, H. Benefits and burden of the maternally-mediated immunological imprinting. Autoimmun. Rev. 8, 394–399 (2009).
Google Scholar
Grindstaff, J. L. Maternal antibodies reduce costs of an immune response during development. (author abstract) (report). J. Exp. Biol. 211, 654 (2008).
Google Scholar
Watts, C. et al. Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen. Immunol. Rev. 164, 11–16 (1998).
Google Scholar
Kim, D., Huey, D., Oglesbee, M. & Niewiesk, S. Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. Blood 117, 6143–6151 (2011).
Google Scholar
Niewiesk, S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front. Immunol. 5, 446 (2014).
Google Scholar
Amer, M. M., Hamouda, A. S. & El-Bayomi, K. M. Studies on maternal antibodies to avian influenza H9N2 vaccine. J. Vet. Med. Res. 20, 268–274 (2010).
Maas, R., Rosema, S., van Zoelen, D. & Venema, S. Maternal immunity against avian influenza H5N1 in chickens: limited protection and interference with vaccine efficacy. Avian Pathol. 40, 87–92 (2011).
Google Scholar
De Vriese, A. J. et al. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies’ interference with the protection elicited by avian influenza-inactivated vaccines in progeny. Avian Dis. 54, 246–252 (2020).
Caminschi, I. & Shortman, K. Boosting antibody responses by targeting antigens to dendritic cells. Trends Immunol. 33, 71–77 (2012).
Google Scholar
Shrestha, A., Jean-Remy, S. & Iqbal, M. Enhancing protective efficacy of poultry vaccines through targeted delivery of antigens to antigen-presenting cells. Vaccines 6, 75 (2018).
Google Scholar
Carayanniotis, G., Skea, D. L., Luscher, M. A. & Barber, B. H. Adjuvant-independent immunization by immunotargeting antigens to MHC and non-MHC determinants in vivo. Mol. Immunol. 28, 261–267 (1991).
Google Scholar
White, A. L. et al. Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant. Immunology 131, 141–151 (2010).
Google Scholar
Bonifaz, L. C. et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815–824 (2004).
Google Scholar
Frleta, D., Demian, D. & Wade, W. F. Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo. Int. Immunopharmacol. 1, 265–275 (2001).
Google Scholar
Caminschi, I. et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112, 3264–3273 (2008).
Google Scholar
Dhodapkar, M. V. et al. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci. Transl. Med. 6, 232ra51 (2014).
Google Scholar
Jáuregui-Zúñiga, D. et al. Targeting antigens to Dec-205 on dendritic cells induces a higher immune response in chickens: Hemagglutinin of avian influenza virus example. Res. Vet. Sci. 111, 55–62 (2017).
Google Scholar
Shrestha, A., Chang, P., Smith, A. & Hulten, M. Van. Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian in fl uenza. npj Vaccines. 6, 1–12 (2021).
Cardenas-Garcia, S. et al. Maternally-derived antibodies protect against challenge with highly pathogenic avian influenza virus of the H7N3 subtype. Vaccines 7, 1–13 (2019).
Kilany, W. H. et al. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus. Avian Pathol. 44, 333–341 (2015).
Google Scholar
Bertran, K. et al. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens. Vaccine 36, 6361–6372 (2018).
Google Scholar
Talat, S. et al. Comparison of the effectiveness of two different vaccination regimes for Avian Influenza H9N2 in broiler chicken. Animals 10, 1875 (2020).
Google Scholar
Hein, R. et al. Review of poultry recombinant vector vaccines. Avian Dis. 65, 438–452 (2021).
Google Scholar
Soejoedono, R. D. et al. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains. Avian Dis. 56, 923–927 (2012).
Google Scholar
Swayne, D. E., Beck, J. R. & Kinney, N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 44, 132–137 (2000).
Google Scholar
Witter, R. & Burmester, B. Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek’s disease vaccines. Avian Pathol. 8, 145–156 (1979).
Google Scholar
Heller, E. D. & Schat, K. A. Enhancement of natural killer cell activity by Marek’s disease vaccines. Avian Pathol. 16, 51–60 (1987).
Google Scholar
Reddy, S. et al. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek’s diseases in specific-pathogen-free chickens. Vaccine 14, 469–477 (1996).
Google Scholar
Weeratna, R. D., Brazolot Millan, C. L., Mccluskie, M. J., Siegrist, C.-A. & Davis, H. L. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies. FEMS Immunol. Med. Microbiol. 30, 241–247 (2001).
Google Scholar
Sedova, E. S. et al. Recombinant Influenza Vaccines. Acta Nat. 4, 17–27 (2012).
Google Scholar
Kim, D. & Niewiesk, S. Synergistic induction of interferon α through TLR-3 and TLR-9 agonists identifies CD21 as interferon α receptor for the B cell response. PLoS Pathog. 9, e1003233 (2013).
Shirota, H. & Klinman, D. M. Recent progress concerning CpG DNA and its use as a vaccine adjuvant. Expert Rev. Vaccines 13, 299–312 (2013).
Google Scholar
Heyman, B., Pilstrom & Shulman, M. Complement activation is required for IgM-mediated enhancement of the antibody response. J. Exp. Med. 167, 1999–2004 (1988).
Google Scholar
Peyre, M. et al. Added value of avian influenza (H5) day-old chick vaccination for disease control in Egypt. Avian Dis. 60, 245–252 (2016).
Google Scholar
De Vriese, J. et al. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies’ interference with the protection elicited by avian influenza–inactivated vaccines in progeny. Avian Dis. 54, 246–252 (2010).
Google Scholar
World Health Organization. WHO Global Influenza. Surveillance Network. WHO Global Influenza Surveillance Network: Manual For The Laboratory Diagnosis and Virological Surveillance of Influenza (WHO, 2011).
